8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)
Published . Updated .
Filed: 2026-10-21 AccNo: 0001493152-26-047841 Size: 226 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- VVOS Vivos Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-21 AccNo: 0001493152-26-047841 Size: 226 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Vivos Therapeutics (VVOS)
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +0.39% | still updating |
| GLD | three days earlier | +1.15% | final price |
| GLD | five days earlier | -0.45% | final price |
| QQQ | that day | +1.29% | still updating |
| QQQ | three days earlier | -1.03% | final price |
| QQQ | five days earlier | +1.64% | final price |
| SPY | that day | +0.60% | still updating |
| SPY | three days earlier | -0.75% | final price |
| SPY | five days earlier | +0.07% | final price |
| TLT | that day | +0.21% | still updating |
| TLT | three days earlier | -0.11% | final price |
| TLT | five days earlier | -1.55% | final price |
| Vivos Therapeutics (VVOS) | that day | -4.26% | still updating |
| Vivos Therapeutics (VVOS) | three days earlier | -6.78% | final price |
| Vivos Therapeutics (VVOS) | five days earlier | -1.23% | final price |
Who gains and who loses around Vivos Therapeutics (VVOS)
Companies carried with this story
- VVOS Vivos Therapeutics
Vivos Therapeutics (VVOS) is linked, with no stored direction, high confidence in the 21 Oct 2026 story “8-K - Vivos Therapeutics, Inc. (0001716166) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> VVOS
How “8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)” reaches Vivos Therapeutics (VVOS)
The 21 Oct 2026 story “8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)” names Vivos Therapeutics (VVOS) because of this story.
The link for Vivos Therapeutics (VVOS) is this: SEC 8-K filing -> direct issuer disclosure -> VVOS
Dates and price levels for Vivos Therapeutics (VVOS)
VVOS traded between 0.12 and 0.15 across 4 sessions. The latest close on file is 0.14.
How strong the case is around Vivos Therapeutics (VVOS)
44 out of 100Price not final
“8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)” scores 44 out of 100. The score uses 1 sources, a -4.86% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.